中国神经再生研究(英文版) ›› 2013, Vol. 8 ›› Issue (7): 622-632.doi: 10.3969/j.issn.1673-5374.2013.07.006
收稿日期:
2012-12-05
修回日期:
2013-02-07
出版日期:
2013-03-05
发布日期:
2013-03-05
Cuicui Yu1, 2, Junke Wang1
Received:
2012-12-05
Revised:
2013-02-07
Online:
2013-03-05
Published:
2013-03-05
Contact:
Junke Wang, Master, Professor, Chief physician, Department of Anesthesiology, First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China, junke45@yahoo.com.
About author:
Cuicui Yu★, Master, Attending physician.
摘要:
盐酸戊乙奎醚可促进微循环,降低血管渗透性,然而盐酸戊乙奎醚在脑缺血再灌注损伤中的作用机制不清。鉴于此,实验建立体内大脑中动脉阻断大鼠模型,于建模前静脉注射盐酸戊乙奎醚。TTC染色、TUNEL和免疫组织化学染色结果显示,盐酸戊乙奎醚能减缓脑缺血再灌注损伤大鼠皮质、海马及纹状体等缺血区神经细胞的病理损伤,减少脑梗死体积,可升高缺血脑组织Bcl-2和降低Caspase-3的表达,抑制再灌注后神经细胞的凋亡。黄嘌呤氧化酶和TBA显色结果显示,盐酸戊乙奎醚可上调脑缺血再灌注损伤大鼠大脑皮质和海马区超氧物歧化酶的活性,下调丙二醛水平,减少大脑兴奋性氨基酸的水平。另外,PCR检测显示盐酸戊乙奎醚可抑制糖氧剥夺条件下体外海马神经细胞 NR1表达。结果证实,盐酸戊乙奎醚可减轻局灶性脑缺血再灌注后的神经细胞凋亡及氧化应激损伤,以此发挥神经保护作用。
. 盐酸戊乙奎醚对脑缺血再灌注损伤的神经保护[J]. 中国神经再生研究(英文版), 2013, 8(7): 622-632.
Cuicui Yu1, Junke Wang. Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia- reperfusion injury[J]. Neural Regeneration Research, 2013, 8(7): 622-632.
[1] Kaushal V, Schlichter LC. Mechanisms of microglia- mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28(9):2221-2230.[2] Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007;87(1):179-197.[3] Minnerup J, Schabitz WR. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics. 2009;6(1):43-52.[4] Annecke T, Kubitz JC, Kahr S, et al. Effects of sevoflurane and propofol on ischaemia-reperfusion injury after thoracic- aortic occlusion in pigs. Br J Anaesth. 2007;98(5): 581-590.[5] Chen Q, Zeng Y. Anisodamine protects against neuronal death following cerebral ischemia in gerbils. Chin Med J (Engl). 2000;113(7):636-639.[6] Guzmán-De La Garza FJ, Cámara-Lemarroy CR, Ballesteros-Elizondo RG, et al. Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/ reperfusion in rats. Surg Today. 2010;40(11):1055-1062. [7] Shen W, Gan J, Xu S, et al. Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Pharmacol Res. 2009;60(4):296-302.[8] Wang LL, Zhan LY, Wu XJ, et al. Effects of penehyclidine hydrochloride on apoptosis of lung tissues in rats with traumatic acute lung injury. Chin J Traumatol. 2010;13(1): 15-19. [9] Han XY, Liu H, Liu CH, et al. Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chem Lett. 2005; 15(8):1979-1982.[10] He SS, Lin CS, Gu MN, et al. Protective effects of penehyclidine hydrochloride against acute renal injury induced by hemorrhagic shock and lipopolysaccharides in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(5):899-902.[11] Xiao HT, Liao Z, Meng XM, et al. Characterization of the effect of penehyclidine hydrochloride on muscarinic receptor subtypes mediating the contraction of guinea-pig isolated gastrointestinal smooth muscle. J Pharm Pharmacol. 2009;61(7):949-952.[12] Wang YA, Zhou WX, Li JX, et al. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Life Sci. 2005;78(2):210-223.[13] Li JT, Ruan JX, Zhang ZQ, et al. Effects of pretreatment with 8018 on the toxicokinetics of soman in rabbits and distribution in mice. Life Sci. 2003;73(8):1053-1062.[14] Gorgulu A, Kins T, Cobanoglu S, et al. Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir (Wien). 2000;142(11):1287-1292.[15] Xiao HT, Liao Z, Meng XM, et al. Underlying mechanism of penehyclidine hydrochloride on isolated rat uterus. Fundam Clin Pharmacol. 2009;23(4):419-421.[16] Zhang YM, Yan YS, Wang LN, et al. A novel rice gene, NRR responds to macronutrient deficiency and regulates root growth. Mol Plant. 2012;5(1):63-72.[17] Hu T, Fu Q, Liu X, et al. Increased acetylcholinesterase and capase-3 expression in the brain and peripheral immune system of focal cerebral ischemic rats. J Neuroimmunol. 2009;211(1-2):84-91.[18] Liu B, Li J, Li L, et al. Electrical stimulation of cerebellar fastigial nucleus promotes the expression of growth arrest and DNA damage inducible gene β and motor function recovery in cerebral ischemia/reperfusion rats. Neurosci Lett. 2012;520(1):110-114.[19] Formichi P, Radi E, Battisti C, et al. Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals. J Cell Mol Med. 2012;16(11):2840-2843.[20] D'Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010;17(7): 1104-1114.[21] Di Menna L, Molinaro G, Di Nuzzo L, et al. Fingolimod protects cultured cortical neurons against excitotoxic death. Pharmacol Res. 2012;67(1):1-9.[22] Gabryel B, Kost A, Kasprowska D. Neuronal autophagy in cerebral ischemia--a potential target for neuroprotective strategies? Pharmacol Rep. 2012;64(1):1-15.[23] Wlodkowic D, Skommer J, Darzynkiewicz Z. Cytometry of apoptosis. Historical perspective and new advances. Exp Oncol. 2012;34(3):255-262.[24] Cheng EH, Kirsch DG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 1997; 278(5345):1966-1968.[25] Tilly JL, Tilly KI, Kenton ML, et al. Expression of members of the Bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive Bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology. 1995;136(1): 232-241.[26] Kim HS, Park MS, Lee JK, et al. Time point expression of apoptosis regulatory proteins in a photochemically- induced focal cerebral ischemic rat brain. Chonnam Med J. 2011;47(3):144-149. [27] Shtilbans V, Wu M, Burstein DE. Evaluation of apoptosis in cytologic specimens. Diagn Cytopathol. 2010;38(9):685-697.[28] Yu SS, Zhao J, Zheng WP, et al. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats. Brain Res. 2010;1308: 167-175.[29] Yang B, El Nahas AM, Thomas GL, et al. Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int. 2001;60(5):1765-1776.[30] Kirsch DG, Doseff A, Chau BN, et al. Caspase-3- dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem. 1999;274(30):21155-21161.[31] Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21(1):92-101. [32] Hovelsø N, Sotty F, Montezinho LP, et al. Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol. 2012;10(1):12-48. [33] Young AB, Fagg GE. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci. 1990;11(3):126-133.[34] Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989;29:365-402.[35] Wei J, Quast MJ. Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation. Brain Res. 1998;791(1-2):146-156.[36] Dawson LA, Djali S, Gonzales C, et al. Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats. Brain Res Bull. 2000;53(6):767-776.[37] Mahesh VB, Brann DW. Regulatory role of excitatory amino acids in reproduction. Endocrine. 2005;28(3):271-280.[38] Javitt DC, Schoepp D, Kalivas PW, et al. Translating glutamate: from pathophysiology to treatment. Sci Transl Med. 2011;3(102):102mr2.[39] Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001; 65(1):1-105.[40] Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001;69(4):369-381.[41] Degracia DJ. Towards a dynamical network view of brain ischemia and reperfusion. Part II: a post-ischemic neuronal state space. J Exp Stroke Transl Med. 2010;3(1):72-89.[42] Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171-182.[43] Farber NB. The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci. 2003;1003:119-130.[44] Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992; 258(5082):597-603.[45] Monyer H, Burnashev N, Laurie DJ, et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12(3):529-540.[46] Luo T, Wu WH, Chen BS. NMDA receptor signaling: death or survival? Front Biol. 2011;6(6):468-476.[47] Santangelo RM, Acker TM, Zimmerman SS, et al. Novel NMDA receptor modulators: an update. Expert Opin Ther Pat. 2012;22(11):1337-1352. [48] Luo X, Baba A, Matsuda T, et al. Susceptibilities to and mechanisms of excitotoxic cell death of adult mouse inner retinal neurons in dissociated culture. Invest Ophthalmol Vis Sci. 2004;45(12):4576-4582.[49] Reiter RJ, Manchester LC, Tan DX. Neurotoxins: free radical mechanisms and melatonin protection. Curr Neuropharmacol. 2010;8(3):194-210.[50] Faustino JV, Wang X, Johnson CE, et al. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci. 2011;31(36):12992-30001.[51] Olmez I, Ozyurt H. Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int. 2012;60(2): 208-212. [52] Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009; 4(6):461-470.[53] Zhao Z, Wang W, Guo H, et al. Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res. 2008;194(1):108-113.[54] Bito T, Nishigori C. Impact of reactive oxygen species on keratinocyte signaling pathways. J Dermatol Sci. 2012; 68(1):3-8. [55] Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 2000;91(1-3):21-27.[56] Shi LL, Chen BN, Gao M, et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats. Life Sci. 2011;88(11-12):521-528. [57] Xiao X, Liu J, Hu J, et al. Protective effects of protopine on hydrogen peroxide-induced oxidative injury of PC12 cells via Ca(2+) antagonism and antioxidant mechanisms. Eur J Pharmacol. 2008;591(1-3):21-27.[58] Yang L, Shah K, Wang H, et al. Characterization of neuroprotective effects of biphalin, an opioid receptor agonist, in a model of focal brain ischemia. J Pharmacol Exp Ther. 2011;339(2):499-508.[59] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.[60] Majid A, He YY, Gidday JM, et al. Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke. 2000;31(11): 2707-2714.[61] Landberg G, Ostlund H, Nielsen NH, et al. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene. 2001;20(27):3497-505.[62] Ruan W, Xu E, Xu F, et al. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biol Ther. 2007;6(3):354-359. [63] Zhou W, Yoshioka M, Yokogoshi H. Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats. J Nutr Sci Vitaminol (Tokyo). 2009;55(4):367-373.[64] Cao Y, Mao X, Sun C, et al. Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Res Bull. 2011;85(6):396-402.[65] Katsube N, Sunaga K, Aishita H, et al. ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. J Pharmacol Exp Ther. 1999;288(1):6-13.[66] Shkryl VM, Nikolaenko LM, Kostyuk PG, et al. High-threshold calcium channel activity in rat hippocampal neurones during hypoxia. Brain Res. 1999;833(2): 319-328.[67] Almeida A, Delgado-Esteban M, Bolanos JP, et al. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J Neurochem. 2002;81(2): 207-217. |
[1] | . 脑源性神经营养因子及相关酶和受体在脑缺氧缺血损伤后起重要作用[J]. 中国神经再生研究(英文版), 2021, 16(8): 1453-1459. |
[2] | . 抑制一氧化氮合酶可加重糖尿病合并创伤性脑损伤大鼠的脑损伤程度[J]. 中国神经再生研究(英文版), 2021, 16(8): 1574-1581. |
[3] | . 神经基质膜包裹周围神经损伤的安全和有效性:一项随机单盲多中心临床试验[J]. 中国神经再生研究(英文版), 2021, 16(8): 1652-1659. |
[4] | . 抑制LncRNA-5657表达可缓解脓毒症脑病大鼠大脑海马中的炎症反应[J]. 中国神经再生研究(英文版), 2021, 16(7): 1288-1293. |
[5] | . microRNA-670可通过Yap通路加剧脑缺血再灌注损伤[J]. 中国神经再生研究(英文版), 2021, 16(6): 1024-1030. |
[6] | . P53诱导糖酵解和凋亡调节因子可减轻缺氧缺血小胶质细胞焦亡和缺血性脑损伤[J]. 中国神经再生研究(英文版), 2021, 16(6): 1037-1043. |
[7] | . Apelin-13抑制脑缺血再灌注损伤后的细胞凋亡和过度自噬[J]. 中国神经再生研究(英文版), 2021, 16(6): 1044-1051. |
[8] | . 短暂吸入七氟醚可减轻新生大鼠缺氧缺血性脑损伤后神经胶质瘢痕的形成[J]. 中国神经再生研究(英文版), 2021, 16(6): 1052-1061. |
[9] | . 复合神经干细胞的胶原/硫酸肝素多孔支架可改善创伤性脑损伤大鼠的神经功能[J]. 中国神经再生研究(英文版), 2021, 16(6): 1068-1077. |
[10] | . 微小RNA-146a纳米颗粒可减轻创伤性脑损伤12h后的炎症反应[J]. 中国神经再生研究(英文版), 2021, 16(3): 514-522. |
[11] | . 三维适形调强放疗修复骨包虫病致坐骨神经损伤效果[J]. 中国神经再生研究(英文版), 2021, 16(3): 580-586. |
[12] | . 脑酐肌肽对缺血性脑卒中溶栓时间窗外的神经保护[J]. 中国神经再生研究(英文版), 2021, 16(2): 312-318. |
[13] | . 创伤性脑损伤仔猪模型中预测性MRI生物标志物的鉴定[J]. 中国神经再生研究(英文版), 2021, 16(2): 338-344. |
[14] | . 山楂叶总黄酮可抑制脊髓损伤后的细胞凋亡并促进运动功能恢复[J]. 中国神经再生研究(英文版), 2021, 16(2): 350-356. |
[15] | . CXCR7中和抗体对脑缺血慢性期海马齿状回神经再生认知功能的影响[J]. 中国神经再生研究(英文版), 2020, 15(6): 1079-1085. |
Design
A randomized, controlled animal experiment.
Time and setting
The experiments were performed at the First Affiliated Hospital of China Medical University in China and Yantai Yuhuangding Hospital Central Laboratory in China from October 2009 to January 2012.
Materials
A total of 24 normal male Sprague-Dawley rats, weighing 250–300 g, aged 10 weeks, and of specific pathogen-free grade, were provided by the Experimental Animal Center of China Medical University, China (license No. SCXK (Liao) 2008-0005).
Penehyclidine hydrochloride (C20H29NO2•HCl) was provided by Lisite Pharmaceutical Co., Ltd., Chengdu City, Sichuan Province, China (batch No. 060502-1). The molecular formula is as follows:
Penehyclidine hydrochloride is a new anticholinergic drug, which can cross the blood-brain barrier and has both anti-muscarinic (M receptor) and anti-nicotinic (N receptor) activities, and retains potent central and peripheral anticholinergic activities. Penehyclidine hydrochloride has been used widely clinically as an antagonist of organic phosphorus and soman poisoning in China. Penehyclidine hydrochloride has little or no effect on M2 receptor subtypes, which has no significant effect on heart rate.
Methods
Establishment of middle cerebral arterial occlusion models in vivo
Middle cerebral arterial occlusion was induced by extracranial vascular occlusion in Sprague-Dawley rats (body weight 250–300 g), according to previously reported procedures with slight modification[58]. Sprague-Dawley rats were anesthetized using 10% (v/v) chloral hydrate via intraperitoneal injection, and body temperature was maintained at 36.5–37.5°C and physiological parameters were monitored continuously during the anesthesia and surgery. Briefly, a 1.5-cm long incision was made at the midline of the neck, the right carotid bifurcation and common carotid artery were separated from the adjacent tissue, avoiding harm to the vagus nerve. After careful isolation of the external carotid artery branches of the occipital and the superior thyroid arteries, as well as the internal carotid artery branch, all of these arteries were exposed. The right common carotid artery and internal carotid artery were carefully separated from the adjacent vagus nerve and connective tissue, and a 0.265-cm diameter nylon intraluminal suture was ligated into the cervical internal carotid artery, advancing intracranially to block blood flow into the middle cerebral artery, and collateral blood flow was also reduced by interrupting all branches of the external carotid artery and all extracranial branches of the internal carotid artery. The suture was withdrawn after occlusion for 120 minutes, and then reperfusion was achieved[59].
Determination of infarction volume in the rat brain
Brain tissues were stored at –70°C for 8 minutes and sliced at a thickness of 2 mm. Slices were incubated in 2% (v/v) 2,3,5-triphenyl-tetrazolium chloride solution for 30 minutes at 37°C. Samples were then washed in distilled water for 30 seconds and photographed. OSIRIS soft 4.19 (http://www.seekbio.com/soft/176.html) was used to measure the infarct area in each sample, and the percentage of the hemispheric infarction volume was calculated. To minimize errors in the estimation of infarction volume, three measurements were needed on each slice for calculation of the infarction volume. The infarction volume (V) was calculated using the following equation:
V= t(A1+A2+…+An), where t is the thickness of the brain tissues (mm), A is the area of the infarcted hemisphere slice (mm2), and n is the number of the brain tissues[60].
Analysis of cell apoptosis in the brain by TUNEL staining
To detect cell apoptosis, TUNEL staining was performed according to the protocol of the TUNEL Detection System (In Site Cell Apoptosis Detection Kit I, POD, MK1020; Boster, Wuhan, Hubei Province, China). Three rats in each group were deeply anesthetized using 10% (v/v) chloral hydrate (300 mg/kg), transcardially perfused with sodium chloride and 4% (w/v) formaldehyde (200 mL), and then decapitated at a given time. Brain samples, including the cortex, hippocampus and striatum, were post-fixed in 4% (w/v) formaldehyde for 2 hours, dehydrated in alcohol, hyalinized by dimethylbenzene, embedded in paraffin, sectioned at a thickness of 4 μm, adhered to superfrost plus slides, and finally stored at room temperature. A standard TUNEL method was employed to detect the fragmented nuclear DNA associated with apoptosis on paraffin sections. After standard deparaffinization, hydration, incubation with proteinase K, and blocking of endogenous peroxidase, tissue sections were incubated with terminal deoxynucleotidyl transferase and digoxigenin-deoxyuridine triphosphate at 37°C for 60 minutes and then with peroxidase converter antibody at 37°C for 30 minutes. For negative controls, some slides were incubated with label solution that did not contain terminal deoxynucleotidyl transferase. Under the optical microscope (Olympus, Tokyo, Japan), the nucleus of apoptotic cells appeared yellow. Positive cells were counted and the mean number in five random views was recorded.
Immunohistochemical staining for Bcl-2 and caspase-3 expression in brain tissues
Formalin-fixed and paraffin-embedded brain sections (5 mm thickness) were first dewaxed in xylene and rehydrated with a graded ethanol series. Endogenous peroxidase was inactivated by incubation in 3% (v/v) H2O2 for 10 minutes at room temperature. Sections were placed in citrate buffer (0.01 M, pH 6.0) for antigen retrieval by microwave heating. Nonspecific binding was blocked by incubation in goat serum (1:10 for 30 minutes at room temperature, and then sections were incubated at 4°C overnight with rabbit anti-Bcl-2 and -caspse-3 polyclonal antibodies (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After three washes in PBS for 15 minutes, the slides were incubated with the appropriate secondary antibody at room temperature for 30 minutes. Slides were incubated in horseradish peroxidase-labeled anti-rabbit IgG (1:200; DAKO, Copenhagen, Denmark) at room temperature for 20 minutes and developed with 3,3’-diaminobenzidine (Sigma, St Louis, MO, USA). The sections were finally counterstained with hematoxylin. For negative-control purposes, the same procedure was used on tissue sections in which 1% (v/v) bovine serum albumin in PBS was substituted for the primary antibody[61-62]. Under the optical microscope (Olympus, Tokyo, Japan), brown particles or patches in the cytoplasm indicated positive staining. Ten fields per section were selected in the cortex and striatum. The numbers of positive cells in the grid were counted and a mean value was recorded.
Detection of excitatory amino acid concentrations in the rat brain
Rats were sacrificed by an overdose of chloral hydrate after 24 hours of reperfusion. Brains were removed from the cranium quickly. The right hemisphere (extracted by professional anatomical staff) of each rat was separated, weighed and immediately mixed with 8% (v/v) sulfosalicylic acid, and then freeze centrifuged at 16 000 r/min for 30 minutes. The supernatant was isolated for analysis. Excitatory amino acid concentrations were measured with a high performance liquid chromatography system (Hitachi, Tokyo, Japan) equipped with a 2.6 × 150.0 mm column using O-phthalaldehyde precolumn derivatization. A mixture of potassium dihydrogen phosphate and 35% (v/v) methanol was run through as mobile phase A, and 90% (v/v) methanol as mobile phase B, at a rate of 1.0 mL/min. Excitatory amino acid concentrations were determined by a calibration curve with known amino acid standards[63].
Measurement of malondialdehyde content and superoxide dismutase activity in the rat brain
Rats were killed immediately after 24 hours of reperfusion. Both sides of the cerebral cortex and hippocampus were separately weighed and stored at –70°C. The samples were homogenized in 0.9% (w/v) saline solution using a homogenizer. The homogenate was then centrifuged at 3 000 r/min for 10 minutes at 4°C. The supernatant obtained was used for assays of malondialdehyde content and superoxide dismutase activity. Malondialdehyde content was determined by the thiobarbituric acid method[64], whereas superoxide dismutase activity was evaluated according to the kit instructions (Jiancheng Institute of Biological Products, Nanjing, Jiangsu Province, China).
Primary culture and establishment of oxygen-glucose deprivation and reperfusion models of hippocampal cells in vitro
Primary cultures of the hippocampus were prepared from 1-day-old Wistar rats based on previously reported articles[65-66]. Briefly, the skin and skull were removed and brain tissue was exposed completely. The bilateral hippocampi were bluntly separated and repeatedly washed with D-Hank’s buffer with 10 μg/mL gentamycin to remove blood vessels and meninges. The dissected pieces were digested in trypsin (0.125% (w/v)) for 20– 25 minutes at 37°C, neutralized with trypsin inhibitor, and washed three times with D-Hank’s buffer. Dissociated cell suspensions of 1 × 106/L density were transferred into Dulbecco’s Modified Eagle Medium buffer with 15% (v/v) serum at 37°C in a humidified atmosphere of 5% (v/v) CO2 in air. Fresh medium was replaced after overnight incubation to remove dead cells and cytarabine was added into the medium on day 3. Half amount of medium was refreshed after overnight incubation, and medium was completely replaced twice per week thereafter. After 8–12 days, oxygen-glucose deprivation and reperfusion was performed. Neuronal cells was incubated with 100 μL Hank’s buffer without glucose at 37°C in 24-well culture plates for 2.5 hours and maintained in a 95% (v/v) N2 and 5% (v/v) CO2 incubator. Oxygen levels in the medium of cultured cells was recovered[67] and the cells were randomly divided into six groups according to treatment with different concentrations of penehyclidine hydrochloride for 20 minutes before oxygen-glucose deprivation/ reperfusion: control group with normal Hank’s buffer, model group, high-dose penehyclidine hydrochloride group (1.6 μM), middle-dose penehyclidine hydrochloride group (0.4 μM), low-dose penehyclidine hydrochloride group (0.1 μM) and MK-801-positive group (0.1 μM), and incubated for 1, 6, 12, 24 hours after reoxygenation.
N-methyl-D-aspartate-NR1 mRNA expression in primary cultured hippocampal cells by reverse transcription-PCR
Total RNA was directly extracted from primary cultured cells using Trizol reagent according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). The absorbance at 260 and 280 nm was measured regularly. The quality of total RNA was examined by running it on a 1% (w/v) agarose/denaturing formaldehyde gel. Samples with a ratio of absorbance at 260 and 280 nm of 1.8–2.0 and a 28s/18s of approximately 2 were qualified for the next round. Three micrograms of total RNA was reverse-transcribed by M-MuLV reverse transcriptase (MBI, Vilmus, Lithuania) with oligo(dT)16 as a primer. Using equal amounts of cDNA, PCR amplification was performed with 20 nM of each primer, 25 mM Mg2+ and 1 U Taq polymerase with the following N-methyl-D- aspartate-NR1 primers (20 mM each) and glyceraldehyde-3-phosphate dehydrogenase primers (20 mM each; Table 1).
All experiments were performed in triplicate. The mRNA level of N-methyl-D-aspartate-NR1 or glyceraldehyde- 3-phosphate dehydrogenase (GAPDH) was assessed by measuring the density of the PCR generated amplicon on the gel by densitometric analysis. The final expression level was the average value of the three amplicons. Relative N-methyl-D-aspartate-NR1 expression is given as N-methyl-D-aspartate-NR1/ GAPDH absorbance ratio.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 software (SPSS, Chicago, IL, USA). Data were expressed as mean ± SD. Statistical comparison was performed by one-way analysis of variance followed by least significant difference test. P values of less than 0.05 were considered statistically significant.
Acknowledgments: We are grateful for the excellent pathology assistance from Professor Weidong Yao, Department of Pathology in the Affiliated Yuhuangding Hospital of Medical College of Qingdao University, China.
Author contributions: Junke Wang and Cuicui Yu contributed equally to the study and results analysis. Both authors approved the final version of the paper.
Conflicts of interest: None declared.
Ethical approval: The experimental procedures were approved by the Animal Use and Care Advisory Committee of Experimental Center of China Medical University in China, and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996).
Author statements: The manuscript is original, has not been submitted to or is not under consideration by another publication, has not been previously published in any language or any form, including electronic, and contains no disclosure of confidential information or authorship/patent application disputations.
null
null
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||